Abiopharma

🔍 TOPOREK MICHAEL (Director)

Company: Capstone Holding Corp. (CAPS)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 1,094,647 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,492,647.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: THE REPORTED SHARES ARE UNVESTED RESTRICTED STOCK AND MAY NOT BE SOLD, TRANSFERRED OR PLEDGED. Including 1,094,647 shares of common stock granted to the Reporting Person on August 7, 2026 as restricted stock awards, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The restricted stock awards will vest in full only upon the Reporting Person's Separation Date, as defined in the Reporting Person's Master Restricted Stock Agreement.